EBS Financial Facts
Research and development: 27.19MInterest expense: -2.05M
See Full Income Statement
Other assets: 1.78M
Deferred tax assets, net: 0
See Full Balance Sheet
Emergent BioSolutions, Inc. (EBS) Earnings
|
Expand Research on EBS
| Next EPS Date | 4/25/24 | EPS Growth Rate | +73.8% |
|---|---|---|---|
| Average EPS % Beat Rate | -421.0% | Revenue Growth Rate | +12.3% |
| Average % Move 1-Wk after EPS | -23.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/9/23 | Q123 | -$3.17 | N/A | N/A | $165.1M | $175.12M | = |  | | Details | |
| 11/4/21 |  |
Q321 | -$0.36 | $2.35 | -$2.71 | $329M | $486.84M | = | | | Details |
| 8/1/22 | Q222 | -$0.86 | $0.38 | -$1.24 | $242.7M | $270.94M | N/A | | | Details | |
| 7/29/21 | |
Q221 | $0.33 | $1.54 | -$1.21 | $397.5M | $398.93M | = | | | Details |
| 8/8/23 | Q223 | -$1.06 | -$0.63 | -$0.43 | $337.9M | $217.03M | = | | | Details | |
5/8/14  |
|
Q114 | -$0.55 | -$0.14 | -$0.41 | $53.9M | $57.3M |  |
| | Details |
| 2/27/23 | Q422 | -$0.31 | $0.04 | -$0.35 | $331M | $297.18M | = | | | Details | |
| 11/8/22 | Q322 | -$0.36 | -$0.07 | -$0.29 | $329M | $268.74M | N/A | | | Details |
